A compensation fund for victims of a nationwide fungal meningitis outbreak blamed on a tainted steroid has grown to $210 million.
The 2012 outbreak killed 64 people and sickened more than 750 in 20 states. They were given an injected steroid produced by now-bankrupt New England Compounding Center of Framingham, Massachusetts.
The Boston Globe reports Saturday court documents show another $70 million in settlements from two companies that did business with the pharmacy.
The settlements must be agreed to by people seeking compensation and a bankruptcy judge. Lawyers told the Globe payments from the fund could start later this year.
Two former New England Compounding executives, co-founder and head pharmacist Barry Cadden and supervisory pharmacist Glenn Chin, have pleaded not guilty to second-degree murder under federal racketeering law. Twelve others also face charges.
